ShadowBuys
Sign inJoin for free

Johnson & Johnson (JNJ)

Healthcare · Drug Manufacturers - General

48 members of Congress have disclosed 174 trades in Johnson & Johnson (JNJ) since 2014: 97 buys and 77 sales. The most recent was disclosed on Oct 30, 2026. 10 trades were made by members of a committee that oversees Johnson & Johnson's industry.

Trades disclosed
174
Members trading
48
Buys / sells
97 / 77
Reported value
$1.3M–$5.1M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow JNJ

Research connections

Patterns in the available disclosures. Each source has its own timing and reporting limits.

2 congressional households disclosed buys

Disclosures in the past 90 days. These may cover different transaction dates and owners.

What else is happening at JNJ

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. JNJFinancial report·SEC EDGAR

    JNJ: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.

    Public: Oct 21, 2026, 4:18 PM EDTEvent / period: Sep 27, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. JNJLobbying report·Lobbying disclosures

    JNJ: third_quarter 2026 lobbying report

    Issues related to the 340B Drug Pricing Program. Issues related to the 340B Drug Pricing Program.

    Public: Oct 20, 2026, 12:00 AM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. JNJLobbying report·Lobbying disclosures

    JNJ: third_quarter 2026 lobbying report

    HR 6549, VA Contracting and Procurement Act PBM Medical Supply Chain program reforms, MSPV, PSAS, IT HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act

    Public: Oct 16, 2026, 12:14 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  4. JNJCompany announcement·SEC EDGAR

    JNJ: Financial results

    Filed 8-K for an event or period dated 2026-10-13. Financial results.

    Public: Oct 13, 2026, 8:12 AM EDTEvent / period: Oct 13, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  5. JNJLobbying report·Lobbying disclosures

    JNJ: third_quarter 2026 lobbying report

    Issues related to the 340B Drug Pricing Program. Issues related to the 340B Drug Pricing Program.

    Public: Aug 14, 2026, 4:15 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees Johnson & Johnson's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded JNJ

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.